Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer

Showing results (241-250 of 280) with videos related to

Pageof 28
Sort By:
Cell|February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAFSonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
British Journal of Cancer|November 1, 1995
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugsD C Blakey, D H Davies, R I Dowell, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Pigment Cell & Melanoma Research|December 17, 2009
Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethalityNathalie Dhomen, Silvy Da Rocha Dias, Robert Hayward, et al.
Plos One|May 26, 2017
Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powderJordan P Ball, Michael J Springer, Yawei Ni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsC J Springer, K D Bagshawe, S K Sharma, et al.
Journal of the American Board of Family Medicine : JABFM|May 10, 2019
Does Ownership Make a Difference in Primary Care Practice?Stephan Lindner, Leif I Solberg, William L Miller, et al.
Journal of Medicinal Chemistry|March 1, 1996
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide linkR I Dowell, C J Springer, D H Davies, et al.
Plos Pathogens|August 22, 2014
Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arborealDeborah J Springer, R Blake Billmyre, Elan E Filler, et al.
Plos One|September 25, 2014
Phylogenetic analysis of phenotypically characterized Cryptococcus laurentii isolates reveals high frequency of cryptic speciesKennio Ferreira-Paim, Thatiana Bragine Ferreira, Leonardo Andrade-Silva, et al.
Pageof 28

Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
Cell|February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAFSonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
British Journal of Cancer|November 1, 1995
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugsD C Blakey, D H Davies, R I Dowell, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 25, 2015
Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxisJ Springer, M Lackner, D Nachbaur, et al.
Pigment Cell & Melanoma Research|December 17, 2009
Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethalityNathalie Dhomen, Silvy Da Rocha Dias, Robert Hayward, et al.
Plos One|May 26, 2017
Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powderJordan P Ball, Michael J Springer, Yawei Ni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsC J Springer, K D Bagshawe, S K Sharma, et al.
Journal of the American Board of Family Medicine : JABFM|May 10, 2019
Does Ownership Make a Difference in Primary Care Practice?Stephan Lindner, Leif I Solberg, William L Miller, et al.
Journal of Medicinal Chemistry|March 1, 1996
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide linkR I Dowell, C J Springer, D H Davies, et al.
Plos Pathogens|August 22, 2014
Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arborealDeborah J Springer, R Blake Billmyre, Elan E Filler, et al.
Plos One|September 25, 2014
Phylogenetic analysis of phenotypically characterized Cryptococcus laurentii isolates reveals high frequency of cryptic speciesKennio Ferreira-Paim, Thatiana Bragine Ferreira, Leonardo Andrade-Silva, et al.
Pageof 28